-
6 oncologists on the move
Six oncologists have joined new practices or received new appointments since Aug. 1. -
Dr. Chaundre Cross lost at sea
Naples, Fla.-based radiation oncologist Chaundre Cross, MD, has been presumed lost at sea after a 100-hour search, NBC News reported Aug. 16. -
Oncology Institute, Blue Note Therapeutics partner on cancer-related digital mental health treatments
Cerritos, Calif.-based Oncology Institute and Blue Note Therapeutics have partnered to provide digital mental health treatment for cancer patients. -
Stage IV cervical cancer diagnoses on the rise: 5 notes
Los Angeles-based researchers found that stage IV cervical cancer diagnoses are on the rise. Here are five findings from their study published Aug. 18 in the International Journal of Gynecological Cancer. -
NIH awards $23M to 4 institutions to study telehealth for cancer centers
The National Cancer Institute, part of the National Institutes of Health, awarded $23 million to four academic institutions to study the role of telehealth in cancer healthcare. -
American Oncology Network speaks out against CMS outpatient payment rule
The American Oncology Network, a community-oncology advocate, spoke against CMS' proposed outpatient payment rule Aug. 15. -
Couple donates $1M for Virginia cancer center
A couple in Roanoke, Va. has donated $1 million to build the city's Carilion Cancer Center, WSLS 10 reported Aug. 18. -
Moffitt Cancer Center expanding to Hillsborough County, Florida
Moffitt Cancer Center agreed to purchase 9acres of land in Hillsborough County, Fla., for a 75,000-square-foot facility, ABC Action News reported Aug. 17. -
Sylvester Comprehensive Cancer Center taps Dr. Sophia George as 1st associate DEI director
Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine appointed Sophia George, PhD, as the inaugural associate director of diversity, equity and inclusion Aug. 16. -
MD Anderson Cancer Center institute forms scientific advisory board
Houston-based James P. Allison Institute at the University of Texas MD Anderson Cancer Center established an 11-person scientific advisory board Aug. 15 to provide strategic guidance and evaluation to its research portfolio and programs. -
3 recent cancer treatment partnerships, alliances
Here are three cancer treatment partnerships or alliances formed since July 22. They are listed in chronological order. -
Viewpoint: How the 'pet effect' can help cancer patients
Pets offer companionship, physical activity and positive motivation. A recent survey of pet owners worldwide found that 87 percent reported a physical or mental benefit to pet ownership, wrote Ashwani Agarwal, MD, in an op-ed for the Corsicana (Texas) Daily Sun. -
UT Southwestern researchers discover brain cancer metastasis pathway
Researchers discovered a molecular pathway responsible for glioblastoma spreading to surrounding brain tissues, as well as an existing drug that hampers growth in animal models, a study in Nature Cell Biology found. -
Salem Hospital reports 2 radiation incidents
Salem (Ore.) Hospital voluntarily reported two incidents within its radiation oncology department to the U.S. Nuclear Regulatory Commission this year, The Statesman Journal reported Aug. 12. -
Moffitt Cancer Center project scrapped
The mayor of St. Petersburg rejected plans for a new Moffitt cancer center, hotel and residential tower, saying the plan didn't include enough affordable community housing, the Tampa Bay Times reported Aug. 12. -
5 recent cancer study findings
Here are five recent oncology-related studies published by Becker's since July 12, starting with the most recent: -
MD Anderson, Empyrean partner on radiation oncology treatments
Houston-based University of Texas MD Anderson Cancer Center and Empyrean Medical Systems, a technology company, entered an exclusive license and joint development agreement Aug. 10. -
Caris Precision Oncology Alliance welcomes Stephenson Cancer Center
OU Health Stephenson Cancer center has joined the Caris Precision Oncology alliance. -
New treatment method reduces brain metastasis in breast cancer patients
An Austrian study led by MedUni Vienna showed a partial or complete regression of brain metastasis in breast cancer patients after treatment with trastuzumab deruxtecan (T-Dxd). -
Oncologists' wealth, debt in 2022: 6 findings
Oncologists’ average income rose about 2 percent to $411,000 in 2022, according to Medscape's "Oncologist Wealth & Debt Report," published Aug. 5.
Page 49 of 50